Researcher Spotlight: Craig Portell, MD University of Virginia Dr. Portell, an Assistant Professor of Medicine at the University of Virginia (UVA), joined UVA’s faculty in order to work with Dr. Michael E. Williams, a Lymphoma Research Foundation (LRF) Scientific…
Researcher Spotlight: Danielle Brander, MD Duke University Dr. Brander is a second year faculty member in the Division of Hematologic Malignancies and Cellular Therapy at Duke University. Her interests as a research clinician are improving and developing novel therapies…
Researcher Spotlight: Natalie Galanina, MD The University of Chicago Though ibrutinib (Imbruvica) has helped a large number of lymphoma patients, many patients treated with ibrutinib eventually develop a resistance to the therapy and relapse. Dr. Galanina’s Lymphoma Clinical Research Mentoring…
Researcher Spotlight: Lapo Alinari, MD, PhD The Ohio State University Dr. Alinari’s Lymphoma Clinical Research Mentoring Program (LCRMP) project investigates the combination of ibrutinib (Imbruvica) and nivolumab (Opdivo) in relapsed or refractory Hodgkin lymphoma (HL) patients. Nivolumab, a PD-1 checkpoint…